Overview

Tranexamic Acid Infusion During Elective Spine Surgery

Status:
Enrolling by invitation
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
Tranexamic acid (TXA) is an agent that has been shown to be safe and effective to reduce blood loss in surgical procedures. The purpose of the study is to assess the effect of transexamic on elective decompressive lumbar spine surgery with and without fusion.
Phase:
Phase 4
Details
Lead Sponsor:
Albany Medical College
Treatments:
Tranexamic Acid